Thermo Fisher Scientific ...

469.89
-19.17 (-3.92%)
At close: Apr 03, 2025, 3:59 PM
468.00
-0.40%
After-hours: Apr 03, 2025, 07:56 PM EDT

Thermo Fisher Scientific Statistics

Share Statistics

Thermo Fisher Scientific has 377.26M shares outstanding. The number of shares has increased by -1.17% in one year.

Shares Outstanding 377.26M
Shares Change (YoY) -1.17%
Shares Change (QoQ) -1.37%
Owned by Institutions (%) 88.22%
Shares Floating 376.61M
Failed to Deliver (FTD) Shares 3
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 3.46M, so 0.91% of the outstanding shares have been sold short.

Short Interest 3.46M
Short % of Shares Out 0.91%
Short % of Float 0.91%
Short Ratio (days to cover) 1.84

Valuation Ratios

The PE ratio is 31.37 and the forward PE ratio is 24.83. Thermo Fisher Scientific's PEG ratio is 4.64.

PE Ratio 31.37
Forward PE 24.83
PS Ratio 4.63
Forward PS 3.3
PB Ratio 4.01
P/FCF Ratio 27.35
PEG Ratio 4.64
Financial Ratio History

Enterprise Valuation

Thermo Fisher Scientific has an Enterprise Value (EV) of 225.99B.

EV / Sales 5.27
EV / EBITDA 19.59
EV / EBIT 26.08
EV / FCF 31.1

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.63.

Current Ratio 1.66
Quick Ratio 1.29
Debt / Equity 0.63
Debt / EBITDA 2.71
Debt / FCF 4.3
Interest Coverage 5.28

Financial Efficiency

Return on Equity is 12.78% and Return on Invested Capital is 7.72%.

Return on Equity 12.78%
Return on Assets 6.51%
Return on Invested Capital 7.72%
Revenue Per Employee $343.03K
Profits Per Employee $50.68K
Employee Count 125,000
Asset Turnover 0.44
Inventory Turnover 4.98

Taxes

Income Tax 657M
Effective Tax Rate 9.34%

Stock Price Statistics

The stock price has increased by -15.05% in the last 52 weeks. The beta is 0.79, so Thermo Fisher Scientific's price volatility has been higher than the market average.

Beta 0.79
52-Week Price Change -15.05%
50-Day Moving Average 537.7
200-Day Moving Average 560.78
Relative Strength Index (RSI) 31.11
Average Volume (20 Days) 1.94M

Income Statement

In the last 12 months, Thermo Fisher Scientific had revenue of 42.88B and earned 6.33B in profits. Earnings per share was 16.58.

Revenue 42.88B
Gross Profit 18.11B
Operating Income 7.34B
Net Income 6.33B
EBITDA 11.54B
EBIT 8.43B
Earnings Per Share (EPS) 16.58
Full Income Statement

Balance Sheet

The company has 4.01B in cash and 31.27B in debt, giving a net cash position of -27.27B.

Cash & Cash Equivalents 4.01B
Total Debt 31.27B
Net Cash -27.27B
Retained Earnings 53.1B
Total Assets 97.32B
Working Capital 8.8B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.67B and capital expenditures -1.4B, giving a free cash flow of 7.27B.

Operating Cash Flow 8.67B
Capital Expenditures -1.4B
Free Cash Flow 7.27B
FCF Per Share 19.02
Full Cash Flow Statement

Margins

Gross margin is 42.23%, with operating and profit margins of 17.11% and 14.77%.

Gross Margin 42.23%
Operating Margin 17.11%
Pretax Margin 16.41%
Profit Margin 14.77%
EBITDA Margin 26.9%
EBIT Margin 17.11%
FCF Margin 16.95%

Dividends & Yields

TMO pays an annual dividend of $1.99, which amounts to a dividend yield of 0.31%.

Dividend Per Share $1.99
Dividend Yield 0.31%
Dividend Growth (YoY) 10.26%
Payout Ratio 12.05%
Earnings Yield 3.19%
FCF Yield 3.66%
Dividend Details

Analyst Forecast

The average price target for TMO is $659, which is 34.7% higher than the current price. The consensus rating is "Buy".

Price Target $659
Price Target Difference 34.7%
Analyst Consensus Buy
Analyst Count 20
Stock Forecasts

Stock Splits

The last stock split was on Jun 6, 1996. It was a forward split with a ratio of 3:2.

Last Split Date Jun 6, 1996
Split Type forward
Split Ratio 3:2

Scores

Altman Z-Score 3.13
Piotroski F-Score 7